Catalyst Wire Dossier Catalyst Wire Dossier

Bifidobacterium infantis 35624

Bifidobacterium infantis 35624 · Procter & Gamble
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bifidobacterium infantis 35624, covering 2011-06-15 to 2011-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome [Phase 3]

See pricing